Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 418

1.

Development and clinical validation of a blood test based on 29-gene expression for early detection of colorectal cancer.

Ciarloni L, Hosseinian Ehrensberger S, Imaizumi N, Monnier-Benoit S, Nichita C, Myung SJ, Kim JS, Song SY, Kim TI, van der Weg B, Meier R, Borovicka J, Beglinger C, Vallet C, Maerten P, Ruegg C, Dorta G.

Clin Cancer Res. 2016 Apr 28. pii: clincanres.2057.2015. [Epub ahead of print]

PMID:
27126992
2.

Gut hormone secretion, gastric emptying and glycemic responses to erythritol and xylitol in lean and obese subjects.

Woelnerhanssen BK, Cajacob L, Keller N, Doody A, Drewe J, Rehfeld JF, Peterli R, Beglinger C, Meyer-Gerspach AC.

Am J Physiol Endocrinol Metab. 2016 Apr 26:ajpendo.00037.2016. doi: 10.1152/ajpendo.00037.2016. [Epub ahead of print]

PMID:
27117004
3.

Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls.

Wölnerhanssen BK, Meyer-Gerspach AC, Peters T, Beglinger C, Peterli R.

Surg Obes Relat Dis. 2015 Nov 27. pii: S1550-7289(15)01075-8. doi: 10.1016/j.soard.2015.11.022. [Epub ahead of print]

4.

Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.

Meyer-Gerspach AC, Cajacob L, Riva D, Herzog R, Drewe J, Beglinger C, Wölnerhanssen BK.

PLoS One. 2016 Mar 4;11(3):e0150803. doi: 10.1371/journal.pone.0150803. eCollection 2016.

5.

Functional roles of low calorie sweeteners on gut function.

Meyer-Gerspach AC, Wölnerhanssen B, Beglinger C.

Physiol Behav. 2016 Feb 6. pii: S0031-9384(16)30044-0. doi: 10.1016/j.physbeh.2016.01.045. [Epub ahead of print] Review.

PMID:
26861179
6.

Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists.

Vavricka SR, Sulz MC, Degen L, Rechner R, Manz M, Biedermann L, Beglinger C, Peter S, Safroneeva E, Rogler G, Schoepfer AM.

Endoscopy. 2016 Mar;48(3):256-62. doi: 10.1055/s-0035-1569674. Epub 2016 Jan 25. No abstract available.

PMID:
26808396
7.

English language version of the S3-consensus guidelines on chronic pancreatitis: Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis.

Hoffmeister A, Mayerle J, Beglinger C, Büchler MW, Bufler P, Dathe K, Fölsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Rünzi M, Schmid RM, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch MM; members of the guideline committee.

Z Gastroenterol. 2015 Dec;53(12):1447-95. doi: 10.1055/s-0041-107379. Epub 2015 Dec 14.

8.

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

Bernsmeier C, Weisskopf DM, Pflueger MO, Mosimann J, Campana B, Terracciano L, Beglinger C, Heim MH, Cajochen C.

PLoS One. 2015 Nov 17;10(11):e0143293. doi: 10.1371/journal.pone.0143293. eCollection 2015.

9.

Gastric emptying and disease activity in inflammatory bowel disease.

Keller J, Binnewies U, Rösch M, Juul Holst J, Beglinger C, Andresen V, Layer P.

Eur J Clin Invest. 2015 Dec;45(12):1234-42. doi: 10.1111/eci.12542. Epub 2015 Nov 2.

PMID:
26426315
10.

Nutritional aspects of depression.

Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S.

Cell Physiol Biochem. 2015;37(3):1029-43. doi: 10.1159/000430229. Epub 2015 Sep 25.

PMID:
26402520
11.

Lean and obese dietary phenotypes: differences in energy and substrate metabolism and appetite.

Clamp L, Hehir AP, Lambert EV, Beglinger C, Goedecke JH.

Br J Nutr. 2015 Nov 28;114(10):1724-33. doi: 10.1017/S0007114515003402. Epub 2015 Sep 18.

PMID:
26382929
12.

Intestinal GLP-1 and satiation: from man to rodents and back.

Steinert RE, Beglinger C, Langhans W.

Int J Obes (Lond). 2016 Feb;40(2):198-205. doi: 10.1038/ijo.2015.172. Epub 2015 Aug 28. Review.

PMID:
26315842
13.

Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI.

Tsai VW, Macia L, Feinle-Bisset C, Manandhar R, Astrup A, Raben A, Lorenzen JK, Schmidt PT, Wiklund F, Pedersen NL, Campbell L, Kriketos A, Xu A, Pengcheng Z, Jia W, Curmi PM, Angstmann CN, Lee-Ng KK, Zhang HP, Marquis CP, Husaini Y, Beglinger C, Lin S, Herzog H, Brown DA, Sainsbury A, Breit SN.

PLoS One. 2015 Jul 24;10(7):e0133362. doi: 10.1371/journal.pone.0133362. eCollection 2015.

14.

Dissociable Behavioral, Physiological and Neural Effects of Acute Glucose and Fructose Ingestion: A Pilot Study.

Wölnerhanssen BK, Meyer-Gerspach AC, Schmidt A, Zimak N, Peterli R, Beglinger C, Borgwardt S.

PLoS One. 2015 Jun 24;10(6):e0130280. doi: 10.1371/journal.pone.0130280. eCollection 2015.

15.

Reply: To PMID 25344905.

Burri E, Beglinger C, Lehmann FS.

Dig Dis Sci. 2015 Apr;60(4):1109-10. No abstract available.

PMID:
26086059
16.

The role and utility of faecal markers in inflammatory bowel disease.

Lehmann FS, Burri E, Beglinger C.

Therap Adv Gastroenterol. 2015 Jan;8(1):23-36. doi: 10.1177/1756283X14553384. Review.

17.

Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis.

Burri E, Beglinger C, von Felten S, Lehmann FS.

Dig Dis Sci. 2015 Feb;60(2):485-91. doi: 10.1007/s10620-014-3383-0. Epub 2014 Oct 26.

PMID:
25344905
18.

Exercise-induced chest pain: an atypical manifestation of eosinophilic esophagitis.

Kahn J, Bussmann C, Beglinger C, Straumann A, Hruz P.

Am J Med. 2015 Feb;128(2):196-9. doi: 10.1016/j.amjmed.2014.08.007. Epub 2014 Sep 23.

PMID:
25261012
19.

IBD: Faecal calprotectin testing--the need for better standardization.

Burri E, Beglinger C.

Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):583-4. doi: 10.1038/nrgastro.2014.154. Epub 2014 Sep 9.

PMID:
25201042
20.

Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations.

Sauter B, Beglinger C, Girardin M, Macpherson A, Michetti P, Schoepfer A, Seibold F, Vavricka SR, Rogler G.

Digestion. 2014;89(4):299-309. doi: 10.1159/000360283. Epub 2014 Jul 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk